Article
New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulation
17 May 2019
Abstract excerpt
Cancer stem cells (CSC) are rare immortal cells within a tumor that are able to initiate tumor progression, development, and resistance. Advances studies show that, like normal stem cells, CSCs can be both self-renewed and given rise to many cell types, therefore form tumors. A number of cell surface markers, such as CD44, CD24, and CD133 are frequently used to identify CSCs. CD133, a transmembrane glycoprotein,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
